Related Experiment Video
Updated: Jun 23, 2026

A Murine Model of Dengue Virus-induced Acute Viral Encephalitis-like Disease
Published on: April 28, 2019
Dengue haemorrhagic fever or dengue shock syndrome in children
1Section of Infectious Diseases, Departments of Medicine and Clinical Epidemiology College of Medicine, University of the Philippines, Manila, The Philippines.
Insights
This systematic review examines supportive treatments for dengue hemorrhagic fever and dengue shock syndrome in children. Evidence on interventions like fluid therapy and blood components is evaluated for effectiveness and safety.
Area of Science:
- Pediatrics
- Infectious Diseases
- Critical Care Medicine
Background:
- Dengue hemorrhagic fever and dengue shock syndrome are significant causes of pediatric hospitalizations and mortality.
- Mortality rates can reach up to 5% without adequate supportive care.
Purpose of the Study:
- To systematically review the effects of supportive treatments for dengue hemorrhagic fever or dengue shock syndrome in children.
- To evaluate the effectiveness and safety of various interventions.
Main Methods:
- Conducted a systematic review of studies including systematic reviews and randomized controlled trials (RCTs).
- Searched major databases (Medline, Embase, Cochrane Library) up to June 2008.
- Included harms alerts from regulatory agencies (FDA, MHRA).
Main Results:
- Included 13 systematic reviews or RCTs meeting the inclusion criteria.
- Performed a GRADE evaluation to assess the quality of evidence for interventions.
Conclusions:
- Presents information on the effectiveness and safety of interventions for pediatric dengue hemorrhagic fever and dengue shock syndrome.
- Evaluated treatments include blood component transfusion, carbazochrome sodium sulfonate, corticosteroids, intravenous immunoglobulin, recombinant-activated factor VII, colloids, crystalloids, and intravenous fluids.
Introduction:
Dengue haemorrhagic fever and dengue shock syndrome are major causes of hospital admission and mortality in children. Up to 5% of people with dengue haemorrhagic fever die of the infection, depending on availability of appropriate supportive care.
Methods And Outcomes:
We conducted a systematic review and aimed to answer the following clinical question: What are the effects of supportive treatments for dengue haemorrhagic fever or dengue shock syndrome in children? We searched: Medline, Embase, The Cochrane Library, and other important databases up to June 2008 (Clinical Evidence reviews are updated periodically, please check our website for the most up-to-date version of this review). We included harms alerts from relevant organisations such as the US Food and Drug Administration (FDA) and the UK Medicines and Healthcare products Regulatory Agency (MHRA).
Results:
We found 13 systematic reviews or RCTs that met our inclusion criteria. We performed a GRADE evaluation of the quality of evidence for interventions.
Conclusions:
In this systematic review we present information relating to the effectiveness and safety of the following interventions: adding blood component transfusion to standard intravenous fluids; adding carbazochrome sodium sulfonate, corticosteroids, or intravenous immunoglobulin to standard intravenous fluids; adding recombinant-activated factor VII to blood component transfusion; colloids; crystalloids; and intravenous fluids.
Related Concept Videos
Blood Pressure Imbalances and Circulatory Shock
Blood Pressure: Hypertension and Hypotension
Normal blood pressure is 120/80 mm Hg. Elevated blood pressure is 120-129/under 80 mm Hg. Hypertension, warranting treatment at 130/80 mm Hg, is often asymptomatic and can lead to severe cardiovascular events, aneurysms, peripheral arterial disease, chronic renal disease, or cardiac...
Yellow Fever
Rocky Mountain Spotted Fever
Diphtheria
Cholera
Hemorrhagic Stroke ll: Pathophysiology

